Title:
CIIP PDA – Eyam Vaccines Immunotherapeutics Ltd – 2023-24
Agreement Number:
7457824 P014186001
Agreement Value:
$2,395.00
Agreement Date:
Feb 29, 2024 - May 1, 2024
Description:
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Organization:
Global Affairs Canada
Expected Results:
Canadian SMEs have increased innovation capacity through increased knowledge and networking opportunities with potential international partnerships in global markets. This Program is linked to the Department’s Results Framework 2.2: Canadian exporters and innovators are successful in their international business development efforts.
Location:
New Westminster, British Columbia, CA V3M 6B9
Reference Number:
064-2024-2025-Q2-00165
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Type:
For-profit organization
Additional Information:
Belated reporting that should have been included in the 2023-2024 4th Quarter report.
Recipient's Operating Name:
Eyam Vaccines and
Recipient's Legal Name:
Eyam Vaccines and
Federal Riding Name:
New Westminster--Burnaby
Federal Riding Number:
59019
Program:
Canadian International Innovation Program (CIIP)
Program Purpose:
The Canadian International Innovation Program (CIIP) fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development. CIIP funding targets the following countries: Brazil, China, India, Israel, and South Korea